Delivery Order SPE2DB22D1017-SPE2DB24FG1DD

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,195.72 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product. The contract has an ultimate completion date of May 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,259.20, is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies. The contract has a performance period ending on June 11, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORTIFOAM 10% AEROSOL 15GM medical products. The contract has a ceiling value of $15,332.04 and a period of performance through September 24, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide these critical medical...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHW48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical supply item, with a ceiling value of $8,818.18 and a completion date of June 24, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This contract award, SPE2DB22D3016|SPE2DB24FAHS6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,403.81, is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies. The contract has a completion date of January 9, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This contract award is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $3,117.12, is a Firm Fixed Price Delivery Order with an ultimate completion date of March 22, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORTIFOAM 10% AEROSOL 15GM. The contract has a firm fixed price of $2,502.08 and an ultimate completion date of August 14, 2024. It is not set aside for a specific business category. Amerisourcebergen Drug Corp has been awarded this contract as part of its extensive work providing a wide range of pharmaceutical products and medical...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF4NL, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,562.92 firm fixed-price delivery order is for the supply of CORTIFOAM 10% AEROSOL 15GM, a medical product, with a performance period through February 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 4564603968 - CORTIFOAM 10% AEROSOL 15GM, a pharmaceutical product. The contract has a ceiling value of $1,845.39 and an ultimate completion date of May 15, 2024. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency awarded a $262,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for CORTIFOAM 10% aerosol. As part of its pharmaceutical supply chain management responsibilities, DLA issued this order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver 15 grams of the topical medication to a customer located in Conshohocken, Pennsylvania by mid-August 2023. No subcontractors or set aside designations were identified. This order...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG1DD
    Delivery Order

This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cortifoam 10% Aerosol 15GM medical supplies. The contract, valued at $1,065.24, is a firm fixed-price delivery order with a completion date of July 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed does not have a specific set-aside designation, indicating open competition.

Generated 5/17/25, 10:11 AM